We
demonstrate microfluidic automation and parallelization of Limulus
amebocyte lysate (LAL)-based bacterial endotoxin testing using centrifugal
microfluidics. LAL is the standard reagent to test for endotoxin contaminations
in injectable pharmaceuticals. The main features of the introduced
system are more than 90% reduction of LAL consumption, from 100 μL/reaction
to 9.6 μL/reaction, automated liquid handling to reduce opportunities
for contamination and manual handling errors, and microfluidic parallelization
by integrating 104 reactions into a single centrifugal microplate.
In a single Eclipse microplate, 21 samples and their positive product
controls are tested in duplicate. In addition, a standard curve with
up to five points is generated, resulting in a total of 104 reactions.
Test samples with a defined concentration of 0.5 endotoxin units per
milliliter were tested, resulting in a coefficient of variation below
0.75%. A key feature for achieving a small coefficient of variation
is ensuring the same path length along the microfluidic channels to
the final reaction chambers for each sample and the reagent, so that
any unspecific adsorption to the polymer surfaces does not affect
the accuracy and precision. Analysis of a sample containing naturally
occurring endotoxin with the developed microfluidic microplate yielded
comparable results to the conventional testing method. A test with
eight commercially available pharmaceuticals was found to pass all
requirements for bacterial endotoxin testing as specified in the United
States Pharmacopeia. The automated endotoxin testing system reveals
specific advantages of centrifugal microfluidics for analytical biochemistry
applications. Small liquid volumes are handled (metered, mixed, and
aliquoted) in a very precise, highly integrated, and highly parallel
manner within mass-fabricated microplates.